Effectiveness of one-stop management using the Angio-CT suite: Impact on acute ischaemic stroke treatment amid and beyond the COVID-19 Era.

Publication date: Jun 05, 2025

During the COVID-19 pandemic, infection control and prevention measures, including chest CT, caused delays in diagnosing and initiating treatment for acute ischemic stroke (AIS). However, conventional imaging workflows were not designed to integrate rapid infection screening and reperfusion therapy. Hence, a new strategy was required to manage treatment effectively. The angio-CT system integrates biplane angiography and sliding gantry CT in a single suite, facilitating one-stop management for AIS treatment. This system provides immediate infection assessment, cerebral perfusion analysis, and endovascular treatment without requiring patient transfers. The current study evaluates the effectiveness of the angio-CT system in reducing treatment delays and improving outcomes for patients with AIS. This single-center, retrospective observational study included 86 consecutive patients who underwent mechanical thrombectomy (MT) for AIS due to ICA or MCA occlusion between April 2020 and March 2024. Patients were divided into conventional and one-stop management groups. Treatment times and clinical outcomes were compared between groups. The one-stop management group significantly reduced door-to-puncture time (53. 0 vs. 87 min, p

Concepts Keywords
April Acute ischemic stroke
Biplane Angio–CT
Improving COVID-19 pandemic
Thrombectomy Mechanical thrombectomy
Stroke management

Semantics

Type Source Name
disease MESH ischaemic stroke
disease MESH COVID-19
disease MESH infection
disease MESH treatment delays
disease MESH Stroke

Original Article

(Visited 1 times, 1 visits today)